Pico Tech - Medical Isotopes

Radiation Detection / Isotopes And Peaks ... Isotopes And Peaks Enlarged ... Isotopes And Peaks Zoomed  / 日本語ページインデックス ... English Documents

Isotope Library files

I made them for my own use, and they are handy for me. However, it may clatter the screen or slow down the system. Keep the original isotope list and please use them with a bit of caution.

There are lots of peaks in these files, even though I included only "small selections" from the main database. Remove/edit as you wish.

For Identify Exe (that comes with PM1703MO-1A/B): Place in the folder where you put Identify Exe. With default installation, it would be C:\Users\UserName\AppData\Roaming\Polimaster\PM PRD PoliIdentify\Identify

Theremino Mca : Put in "Extra" Folder under ThereminoMCA. Create a copy of original data, rename as "Isotopes_Energy.txt"

BecqMoni : Put in the "config" folder. Create a copy of original data, rename as "NuclideDefinition.xml"

List of Medical Isotopes

This seems to be more extensive than another one. So, I used this for creating the library for medical isotope, for Identify Exe , Theremino Mca , and BecqMoni.

From http://wiki.answers.com/Q/List_of_isotopes_used_in_medical_field

Ac-225 10.0d Monoclonal antibody attachment used for cancer treatment (RIT), also parent of Bi-213.
Ac-227 21.8y Parent of Ra-223 (Monoclonal antibody attachment used for cancer treatment (RIT).
Am-241 432y Osteoporosis detection, heart imaging.
As-72 26.0h Planar imaging, SPECT or PET.
As-74 17.8d Positron-emitting isotope with biomedical applications.
At-211 7.21h Monoclonal antibody attachment (alpha emitter) used for cancer treatment (RIT), used with F-18 for in vivo studies.
Au-198 2.69d Cancer treatment using mini-gun (B), treating ovarian, prostate, and brain cancer.
B-11 Stable Melanoma and brain tumor treatment.
Be-7 53.2d Used in berylliosis studies.
Bi-212 1.10h Monoclonal antibody attachment (alpha emitter) used for cancer treatment (RIT), cellular dosimetry studies.
Bi-213 45.6m Monoclonal antibody attachment (alpha emitter) used for cancer treatment (RIT).
Br-75 98m Planar imaging, SPECT or PET (C).
Br-77 57h Label radiosentizers for Te quantization of hypoxia in tumors, and monoclonal antibody labeling.
C-11 20.3m Radiotracer in PET scans to study normal/abnormal brain functions.
C-14 5730y Radiolabeling for detection of tumors (breast, et al.).
Ca-48 Stable
Cd-109 462d Cancer detection (C), pediatric imaging (C).
Ce-139 138d Calibrates high-purity germanium gamma detectors.
Ce-141 32.5d Gastrointestinal tract diagnosis, measuring regional myocardial blood flow.
Cf-252 2.64y Cervical, melanoma, brain cancer treatment.
Co-55 17.5h Planar imaging, SPECT or PET (B). Used in PET imaging of damaged brain tissue after stroke.
Co-57 272d Gamma camera calibration, should be given high priority, radiotracer in research and a source for X-ray fluorescence spectroscopy.
Co-60 5.27y Teletherapy (destroy cancer cells), disinfect surgical equipment and medicines, external radiation cancer therapy (E).
Cr-51 27.7d Medical, cell labeling and dosimetry.
Cs-130 29.2m Myocardial localizing agent.
Cs-131 9.69d Intracavity implants for radiotherapy.
Cs-137 30.2y Blood irradiators, PET imaging, tumor treatment.
Cu-61 3.35h Planar imaging, SPECT or PET (B).
Cu-62 4.7m Positron emitting radionuclide (B), cerebral and myocardial blood flow used As-a tracer in conjunction with Cu 64 (B).
Cu-64 12.7h PET scanning (C), planar imaging (C), SPECT imaging (C) dosimetry studies (C), cerebral and myocardial blood flow (C), used with Cu-62 (C), treating of colorectal cancer.
Cu-67 61.9h Cancer treatment/diagnostics, monoclonal antibodies, radioimmunotherapy, planar imaging, SPECT or PET.
Dy-165 2.33h Radiation synovectomy, rheumatoid arthritis treatment.
Eu-152 13.4y Medical.
Eu-155 4.73y Osteoporosis detection.
F-18 110m Radiotracer for brain studies (C), PET imaging (C).
Fe-55 2.73y Heat source.
Fe-59 44.5d Medical.
Ga-64 2.63m Treatment of pulmonary diseases ending in fibrosis of lungs.
Ga-67 78.3h Imaging of abdominal infections (C), detect Hodgkins/non-Hodgkins lymphoma (C), used with In-111 for soft tissue infections and osteomyelitis detection (C), evaluate sarcoidiodis and other granulomaous diseases, particularly in lungs and mediastiusim (C).
Ga-68 68.1m Study thrombosis and atherosclerosis, PET imaging, detection of pancreatic cancer, attenuation correction.
Gd-153 242d Dual photon source, osteoporosis detection, SPECT imaging.
Ge-68 271d PET imaging.
H-3 12.3y Labeling, PET imaging.
I-122 3.6m Brain blood flow studies.
I-123 13.1h Brain, thyroid, kidney, and myocardial imaging (C), cerebral blood flow (ideal for imaging) (C), neurological disease (Alzheimer's) (C).
I-124 4.17d Radiotracer used to create images of human thyroid, PET imaging.
I-125 59.9d Osteoporosis detection, diagnostic imaging, tracer for drugs, monoclonal antibodies, brain cancer treatment (I-131 replacement), SPECT imaging, radiolabeling, tumor imaging, mapping of receptors in the brain (A), interstitial radiation therapy (brachytherapy) for treatment of prostate cancer (E).
I-131 8.04d Lymphoid tissue tumor/hyperthyroidism treatment (C), antibody labeling (C), brain biochemistry in mental illness (C), kidney agent (C), thyroid problems (C), alternative to Tl-201 for radioimmunotherapy (C), imaging, cellular dosimetry, scintigraphy, treatment of graves disease, treatment of goiters, SPECT imaging, treatment of prostate cancer, treatment of hepatocellular carcinoma, treatment of melanoma (A), locate osteomyelitis infections (A), radiolabeling (A), localize tumors for removal (A), treatment of spinal tumor (A), locate metastatic lesions (A), treAt-neuroblastoma (A), internal (systemic) radiation therapy (E), treatment of carcinoma of the thyroid (E).
I-132 2.28h Mapping precise area of brain tumor before operating.
In-111 2.81d Detection of heart transplant rejection (C), imaging of abdominal infections (C), antibody labeling (C) cellular immunology (C), used with Ga-67 for soft tissue infection detection and ostemyelitis detection (C), concentrates in liver, kidneys (C), high specific activity (C), white blood cell imaging, cellular dosimetry, myocardial scans, treatment of leukemia, imaging tumors.
In-115m 4.49h Label blood elements for evaluating inflammatory bowel disease.
Ir-191m 6s Cardiovascular angiography.
Ir-192 73.8d Implants or "seeds" for treatment of cancers of the prostate, brain, breast, gynecological cancers.
Kr-81m 13.3s Lung imaging.
Lu-177 6.68d Heart disease treatment (restenosis therapy), cancer therapy.
Mn-51 46.2m Myocardial localizing agent.
Mn-52 5.59d PET scanning.
Mo-99 65.9h Parent for Tc-99m generator used for brain, liver, lungs, heart imaging.
N-13 9.97m PET imaging, myocardial perfusion.
Nb-95 35d Study effects of radioactivity on pregnant women and fetus, myocardial tracer, PET imaging.
O-15 122s Water used for tomographic measuring of cerebral blood flow (C), PET imaging (C), SPECT imaging.
Os-191 15.4d Parent for Ir-191m generator used for cardiovascular angiography.
Os-194 6.00y Monoclonal antibody attachment used for cancer treatment (RIT).
P-32 14.3d Polycythaemia Rubra Vera (blood cell disease) and leukemia treatment, bone disease diagnosis/treatment, SPECT imaging of tumors (A), pancreatic cancer treatment (A), radiolabeling (A).
P-33 25d Labeling.
Pb-203 2.16d Planar imaging, SPECT or PET (used with Bi-212) (B), monoclonal antibody immunotherapy (B), cellular dosimetry.
Pb-212 10.6h Radioactive label for therapy using antibodies, cellular dosimetry.
Pd-103 17d Prostate cancer treatment.
Pd-109 13.4h Potential radiotherapeutic agent.
Pu-238 2.3y Pacemaker (no Pu-236 contaminants).
Ra-223 11.4d Monoclonal antibody attachment (alpha emitter) used for cancer treatment (RIT).
Ra-226 1.60e3y Target isotope to make Ac-227, Th-228, Th-229 (Parents of alpha emitters used for RIT).
Rb-82 1.27m Myocardial imaging agent, early detection of coronary artery disease, PET imaging, blood flow tracers.
Re-186 3.9d Cancer treatment/diagnostics, monoclonal antibodies, bone cancer pain relief, treatment of rheumatoid arthritis, treatment of prostate cancer, treating bone pain.
Re-188 17h Monoclonal antibodies, cancer treatment.
Rh-105 35.4h Potential therapeutic applications: target neoplastic cells (e.g., small cell lung cancer) (A), labeling of molecules and monoclonal antibodies (A).
Ru-97 2.89d Monoclonal antibodies label (C), planar imaging (C), SPECT or PET techniques (C), gamma-camera imaging.
Ru-103 39d Myocardial blood flow, radiolabeling mircospheres, PET imaging.
S-35 87.2d Nucleic acid labeling, P-32 replacement, cellular dosimetry.
Sc-46 84d Regional blood flow studies, PET imaging.
Sc-47 3.34d Cancer treatment/diagnostics (F), monoclonal antibodies (F), radioimmunotherapy (F).
Se-72 8.4d Brain imaging, generator system with As-72, monoclonal antibody immunotherapy.
Se-75 120d Radiotracer used in brain studies, scintigraphy scanning.
Si-28 Stable Radiation therapy of cancer.
Sm-145 340d Brain cancer treatment using I-127 (D).
Sm-153 2.00d Cancer treatment/diagnostics (C), monoclonal antibodies (C), bone cancer pain relief (C), higher uptake in diseased bone than Re-186 (C), treatment of leukemia.
Sn-117m 13.6d Bone cancer pain relief.
Sr-85 65.0d Detection of focal bone lesions, brain scans.
Sr-89 50d Bone cancer pain palliation (improves the quality of life), cellular dosimetry, treatment of prostate cancer, treatment of multiple myeloma, osteoblastic therapy, potential agent for treatment of bone metastases from prostate and breast cancer (E).
Sr-90 29.1y Generator system with Y-90 (B), monoclonal antibody immunotherapy (B).
Ta-178 9.3m Radionuclide injected into patients to allow viewing of heart and blood vessels.
Ta-179 1.8y X-ray fluorescence source and in thickness gauging (might be a good substitute for Am-241).
Ta-182 115d Bladder cancer treatment, internal implants.
Tb-149 4.13h Monoclonal antibody attachment used for cancer treatment (RIT).
Tc-96 4.3d Animal studies with Tc-99m.
Tc-99m 6.01h Brain, heart, liver (gastoenterology), lungs, bones, thyroid, and kidney imaging (C), regional cerebral blood flow (C), equine nuclear imaging (C), antibodies (C), red blood cells (C), replacement for Tl-201 (C).
Th-228 720d Cancer treatment, monoclonal antibodies, parent of Bi-212.
Th-229 7300y Grandparent for alpha emitter (Bi-213) used for cancer treatment (RIT), parent of Ac-225.
Tl-201 73.1h Clinical cardiology (C), heart imaging (C), less desirable nuclear characteristics than Tc-99m for planar and SPECT imaging (C), myocardial perfusion, cellular dosimetry.
Tm-170 129d Portable blood irradiations for leukemia, lymphoma treatment, power source.
Tm-171 1.9y Medical.
W-188 69.4d Cancer treatment, monoclonal antibodies, parent for Re-188 generator.
Xe-127 36.4d Neuroimaging for brain disorders, research for variety of neuropsychiatric disorders, especially schizophrenia and dementia, higher resolution SPECT studies with lower patient dose, lung imaging (some experts believe it is superior to Xe-133 in inhalation lung studies).
Xe-133 5.25d Lung imaging (C), regional cerebral blood flow (C), liver imaging (gas inhalation) (C), SPECT imaging of brain, lung scanning, lesion detection.
Y-88 107d Substituted for Y-90 in development of cancer tumor therapy.
Y-90 64h Internal radiation therapy of liver cancer (C), monoclonal antibodies (C), Hodgkins disease, and hepatoma (C), cellular dosimetry, treating rheumatoid arthritis, treating breast cancer, treatment of gastrointestinal adenocarcinomas (A).
Y-91 58.5d Cancer treatment (RIT), cellular dosimetry.
Yb-169 32d Gastrointestinal tract diagnosis.
Zn-62 9.22h Parent of Cu-62, a positron-emitter, used for the study of cerebral and myocardial blood flow.
Zn-65 244d Medical.
Zr-95 64.0d Medical.

Another list that contains less isotopes.

From http://answers.yahoo.com/question/index?qid=20060904023619AAW8Wz1

Molybdenum-99 (66 h): Used as the 'parent' in a generator to produce technetium-99m.

Technetium-99m (6 h): Used in to image the skeleton and heart muscle in particular, but also for brain, thyroid, lungs (perfusion and ventilation), liver, spleen, kidney (structure and filtration rate), gall bladder, bone marrow, salivary and lacrimal glands, heart blood pool, infection and numerous specialised medical studies.

Bismuth-213 (46 min): Used for TAT.

Chromium-51 (28 d): Used to label red blood cells and quantify gastro-intestinal protein loss.

Cobalt-60 (10.5 mth): Formerly used for external beam radiotherapy.

Copper-64 (13 h): Used to study genetic diseases affecting copper metabolism, such as Wilson's and Menke's diseases.

Dysprosium-165 (2 h): Used as an aggregated hydroxide for synovectomy treatment of arthritis.

Erbium-169 (9.4 d): Use for relieving arthritis pain in synovial joints.

Holmium-166 (26 h): Being developed for diagnosis and treatment of liver tumours.

Iodine-125 (60 d): Used in cancer brachytherapy (prostate and brain), also diagnostically to evaluate the filtration rate of kidneys and to diagnose deep vein thrombosis in the leg. It is also widely used in radioimmuno-assays to show the presence of hormones in tiny quantities.

Iodine-131 (8 d): Widely used in treating thyroid cancer and in imaging the thyroid; also in diagnosis of abnormal liver function, renal (kidney) blood flow and urinary tract obstruction. A strong gamma emitter, but used for beta therapy.

Iridium-192 (74 d): Supplied in wire form for use as an internal radiotherapy source for cancer treatment (used then removed).

Iron-59 (46 d): Used in studies of iron metabolism in the spleen.

Lutetium-177 (6.7 d): Lu-177 is increasingly important as it emits just enough gamma for imaging while the beta radiation does the therapy on small (eg endocrine) tumours. Its half-life is long enough to allow sophisticated preparation for use.

Palladium-103 (17 d): Used to make brachytherapy permanent implant seeds for early stage prostate cancer.

Phosphorus-32 (14 d): Used in the treatment of polycythemia vera (excess red blood cells). Beta emitter.

Potassium-42 (12 h): Used for the determination of exchangeable potassium in coronary blood flow.

Rhenium-186 (3.8 d): Used for pain relief in bone cancer. Beta emitter with weak gamma for imaging.

Rhenium-188 (17 h): Used to beta irradiate coronary arteries from an angioplasty balloon.

Samarium-153 (47 h): Sm-153 is very effective in relieving the pain of secondary cancers lodged in the bone, sold as Quadramet. Also very effective for prostate and breast cancer. Beta emitter.

Selenium-75 (120 d): Used in the form of seleno-methionine to study the production of digestive enzymes.

Sodium-24 (15 h): For studies of electrolytes within the body.

Strontium-89 (50 d): Very effective in reducing the pain of prostate and bone cancer. Beta emitter.

Xenon-133 (5 d): Used for pulmonary (lung) ventilation studies.

Ytterbium-169 (32 d): Used for cerebrospinal fluid studies in the brain.

Ytterbium-177 (1.9 h): Progenitor of Lu-177.

Yttrium-90 (64 h): Used for cancer brachytherapy and as silicate colloid for the relieving the pain of arthritis in larger synovial joints. Pure beta emitter.

Radioisotopes of caesium, gold and ruthenium are also used in brachytherapy.

Cyclotron Radioisotopes

Carbon-11, Nitrogen-13, Oxygen-15, Fluorine-18:
These are positron emitters used in PET for studying brain physiology and pathology, in particular for localising epileptic focus, and in dementia, psychiatry and neuropharmacology studies. They also have a significant role in cardiology. F-18 in FDG has become very important in detection of cancers and the monitoring of progress in their treatment, using PET.

Cobalt-57 (272 d): Used as a marker to estimate organ size and for in-vitro diagnostic kits.

Gallium-67 (78 h): Used for tumour imaging and localisation of inflammatory lesions (infections).

Indium-111 (2.8 d): Used for specialist diagnostic studies, eg brain studies, infection and colon transit studies.

Iodine-123 (13 h): Increasingly used for diagnosis of thyroid function, it is a gamma emitter without the beta radiation of I-131.

Krypton-81m (13 sec) from Rubidium-81 (4.6 h): Kr-81m gas can yield functional images of pulmonary ventilation, e.g. in asthmatic patients, and for the early diagnosis of lung diseases and function.

Rubidium-82 (65 h): Convenient PET agent in myocardial perfusion imaging.

Strontium-92 (25 d): Used as the 'parent' in a generator to produce Rb-82.

Thallium-201 (73 h): Used for diagnosis of coronary artery disease other heart conditions such as heart muscle death and for location of low-grade lymphomas.

Hope this will do for you !

Last modified : Fri Sep 6 17:26:28 2013 Maintained by nkom AT pico.dreamhosters.com